ClinicalTrials.Veeva

Menu

Effects of Grape Consumption on the Immune-Gut Axis in Obesity

University of Missouri (MU) logo

University of Missouri (MU)

Status

Enrolling

Conditions

Obesity &Amp; Overweight

Treatments

Other: Freeze-dried grape powder
Other: Placebo powder

Study type

Interventional

Funder types

Other

Identifiers

NCT07231484
2128808

Details and patient eligibility

About

This study is investigating the benefits of whole freeze-dried grape powder consumption on the immune-gut axis in adults with obesity.

Full description

The study is a 12-wk randomized, controlled, crossover trial. Participants will be randomized to one of two intervention sequences, either consuming 48g/day of whole freeze-dried grape powder followed by an isocaloric placebo powder or consuming the placebo powder followed by the whole freeze-dried grape powder. Active intervention phases will be 4 weeks in duration followed by a 4-week washout period between treatments.

Enrollment

50 estimated patients

Sex

All

Ages

30 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age: 30-45 years
  • Obesity with BMI of 30-45 kg/m2
  • Willingness to consume study foods
  • Consistent diet and activity patterns for 4 weeks
  • Weight stable (<5kg change over last 3 months)
  • Non-smoker > 1 year or more
  • Not currently consuming an extremely healthy diet

Exclusion criteria

  • Study food allergies
  • Regular consumption of grapes or grape-derived products
  • Gastrointestinal disease and/or bariatric surgery
  • Uncontrolled hypertension and blood pressure >180/110
  • Diabetes
  • Clinical Depression
  • Illicit drug use
  • History of alcohol or drug abuse
  • Recent use of medications that affect immune function (e.g., corticosteroids)
  • Recent consumption of antibiotics, prebiotics, probiotics, symbiotics, or dietary supplements containing fiber or phytochemicals
  • Pregnant or lactating individuals
  • HIV positivity
  • Recent start of medications that affect metabolism or appetite
  • Drug therapy for coronary artery disease, peripheral artery disease, congestive heart failure, or dyslipidemia

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

50 participants in 2 patient groups

Sequence 1: Grape then Placebo
Experimental group
Description:
Whole freeze-dried grape powder for 4 weeks, 4-week washout, then isocaloric placebo powder for 4 weeks.
Treatment:
Other: Placebo powder
Other: Freeze-dried grape powder
Sequence 2: Placebo then Grape
Experimental group
Description:
Isocaloric placebo powder for 4 weeks, 4-week washout, then whole freeze-dried grape powder for 4 weeks.
Treatment:
Other: Placebo powder
Other: Freeze-dried grape powder

Trial contacts and locations

1

Loading...

Central trial contact

Jaapna Dhillon PhD, PhD; Caitlyn Winn, MS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems